Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford Mail, 22/03/2013, p.2

Chief medical officer dementia study 2018will help many2019

The Chief Medical Officer came to Oxford yesterday to officially launch a research project aimed at tackling dementia. The £3.75m Clinical Research Facility is spread across a number of sites in the city. It includes two units at Oxford University’s Department of Experimental Psychology (the Oxford Centre for Anxiety Disorders and Trauma and the Oxford Cognitive Neuropsychology Centre); the Clinical Research Facility at the Warneford Hospital, and the Charles Wolfson Clinical Neuroscience Facility in the West Wing of the John Radcliffe Hospital. Professor Dame Sally Davies, who is also chief scientific adviser at the Department of Health, said: “Cognitive health is a really important area for research because it affects large numbers of people, and includes conditions such as dementia, communication impairments in children, social anxiety disorder, post-traumatic stress disorder, depression, schizophrenia and stroke.”

See also:

Chief Medical Officer opens new research facility in Oxford (Oxford University News) &

Chief Medical Officer opens new research facility for dementia, mental health and neuroscience in Oxford (Medical Science Division News)